Study Details
Testing the drug XEN1101 for People with Primary Generalized Tonic-Clonic Seizures
(IRB#: IRB_00159508)
Primary generalized tonic-clonic seizures are seizures that start in both sides of the brain at the same time. This study will test a drug called XEN1101 to treat adults with this disease. The study wants to see if the drug will help people with the disease and is safe. People in the study will be randomly chosen to be treated with XEN1101 or a placebo. A placebo looks like the drug but does not contain the medication. Being in the study requires attending in-person visits at the study clinic, with some phone call visits too. The study lasts up to about 29.5 weeks. Medical tests will be done during the study to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18 to 75 years old
- Diagnosed with primary generalized tonic clonic seizures
- Must use specific birth control
- Write in a seizure diary
- Able to attend in person visits at the study clinic
Exclusion Criteria
- Seizure type does not fit correct diagnosis
- History of drug or alcohol abuse
- Medical test results are out of the normal range for participation
- Mental health concerns
- Pregnant
Will I be paid for my time?
Yes
IRB#: IRB_00159508
PI: Amir Arain
Department: NEUROLOGY
Approval Date: 2023-08-16 06:00:00
Study Categories: Brain Health Studies
Specialties: Neurology
I am Interested